Glaukos Corp Note 2.750% 6/1 (Principal)
|
8.0 |
$359M |
|
270M |
1.33 |
Nuvalent Inc-a
(NUVL)
|
6.0 |
$269M |
|
19M |
13.89 |
Viatris
(VTRS)
|
5.0 |
$225M |
|
21M |
10.88 |
Adapthealth Corp Common Stock
(AHCO)
|
4.2 |
$187M |
|
12M |
16.03 |
Invitae Corp Note 2.000% 9/0 (Principal)
|
3.8 |
$170M |
|
207M |
0.82 |
Neurocrine Biosciences
(NBIX)
|
3.5 |
$155M |
|
1.7M |
93.75 |
Aerie Pharmaceuticals Note 1.500%10/0 (Principal)
|
3.2 |
$142M |
|
157M |
0.90 |
Envista Holdings Corporation Note 2.375% 6/0 (Principal)
|
2.8 |
$124M |
|
53M |
2.36 |
Caremax Com Cl A
|
2.7 |
$122M |
|
16M |
7.68 |
Natera Note 2.250% 5/0 (Principal)
|
2.7 |
$120M |
|
91M |
1.33 |
Sarepta Therapeutics DBCV 1.500%11/1
|
2.6 |
$116M |
|
89M |
1.31 |
Pacira Biosciences Note 0.750% 8/0 (Principal)
|
2.3 |
$101M |
|
82M |
1.24 |
Nuvasive Note 1.000% 6/0 (Principal)
|
2.2 |
$96M |
|
97M |
0.99 |
Pulmonx Corp
(LUNG)
|
2.0 |
$92M |
|
3.7M |
24.81 |
Silk Road Medical Inc Common
(SILK)
|
2.0 |
$89M |
|
2.2M |
41.29 |
Iveric Bio
|
1.8 |
$82M |
|
4.9M |
16.83 |
Apellis Pharmaceuticals Note 3.500% 9/1 (Principal)
|
1.8 |
$82M |
|
52M |
1.58 |
Tabula Rasa Healthcare Note 1.750% 2/1 (Principal)
|
1.8 |
$80M |
|
108M |
0.74 |
Insulet Corp Note 0.375% 9/0 (Principal)
|
1.7 |
$76M |
|
58M |
1.32 |
Nuvasive Note 0.375% 3/1 (Principal)
|
1.7 |
$76M |
|
80M |
0.95 |
Insmed Note 1.750% 1/1 (Principal)
|
1.7 |
$75M |
|
75M |
1.00 |
Mirum Pharmaceuticals
(MIRM)
|
1.6 |
$72M |
|
3.3M |
22.02 |
Kura Oncology
(KURA)
|
1.6 |
$71M |
|
4.4M |
16.08 |
Nevro Corp Note 2.750% 4/0 (Principal)
|
1.5 |
$65M |
|
61M |
1.07 |
Organogenesis Hldgs
(ORGO)
|
1.4 |
$64M |
|
8.5M |
7.62 |
Intercept Pharmaceuticals In Note 3.250% 7/0 (Principal)
|
1.2 |
$53M |
|
58M |
0.92 |
Deciphera Pharmaceuticals
(DCPH)
|
1.2 |
$52M |
|
5.6M |
9.27 |
Horizon Therapeutics Pub L SHS
|
1.1 |
$49M |
|
465k |
105.21 |
Bridgebio Pharma Note 2.500% 3/1 (Principal)
|
1.1 |
$47M |
|
80M |
0.59 |
Centene Corporation
(CNC)
|
1.0 |
$47M |
|
554k |
84.19 |
Gilead Sciences
(GILD)
|
1.0 |
$46M |
|
766k |
59.45 |
Molina Healthcare
(MOH)
|
1.0 |
$45M |
|
135k |
333.59 |
Aerie Pharmaceuticals
|
1.0 |
$43M |
|
4.7M |
9.10 |
Sema4 Holdings Corp Com Cl A
|
1.0 |
$43M |
|
14M |
3.07 |
Singular Genomics Systems In
(OMIC)
|
0.9 |
$42M |
|
6.6M |
6.31 |
Alphatec Hldgs Com New
(ATEC)
|
0.9 |
$41M |
|
3.6M |
11.50 |
Edgewise Therapeutics
(EWTX)
|
0.9 |
$38M |
|
3.9M |
9.70 |
Brookdale Senior Living
(BKD)
|
0.8 |
$38M |
|
5.4M |
7.05 |
Cytokinetics Com New
(CYTK)
|
0.8 |
$35M |
|
953k |
36.81 |
1life Healthcare Note 3.000% 6/1 (Principal)
|
0.8 |
$35M |
|
40M |
0.87 |
Oncology Institu
(TOI)
|
0.7 |
$32M |
|
3.3M |
9.75 |
Pharvaris N V
(PHVS)
|
0.6 |
$29M |
|
1.6M |
18.13 |
Novavax Note 3.750% 2/0 (Principal)
|
0.6 |
$27M |
|
25M |
1.07 |
Bellus Health Com New
|
0.6 |
$25M |
|
3.7M |
6.88 |
Glaukos
(GKOS)
|
0.5 |
$24M |
|
415k |
57.82 |
Larimar Therapeutics
(LRMR)
|
0.5 |
$24M |
|
5.8M |
4.05 |
Revolution Medicines
(RVMD)
|
0.5 |
$23M |
|
892k |
25.51 |
Mirati Therapeutics
|
0.5 |
$22M |
|
270k |
82.22 |
Xeris Biopharma Holdings Note 5.000% 7/1 (Principal)
|
0.5 |
$21M |
|
18M |
1.17 |
Day One Biopharmaceuticals I
(DAWN)
|
0.5 |
$21M |
|
2.1M |
9.92 |
Goodrx Hldgs Com Cl A
(GDRX)
|
0.4 |
$19M |
|
979k |
19.33 |
Nuvation Bio Com Cl A
(NUVB)
|
0.4 |
$19M |
|
3.6M |
5.26 |
Outset Med
(OM)
|
0.4 |
$18M |
|
401k |
45.40 |
Health Catalyst Note 2.500% 4/1 (Principal)
|
0.4 |
$17M |
|
15M |
1.14 |
ImmunoGen
|
0.4 |
$17M |
|
3.5M |
4.76 |
BioCryst Pharmaceuticals
(BCRX)
|
0.4 |
$17M |
|
1.0M |
16.26 |
Da32 Life Scnce Tec Acqstn C Class A Com
|
0.3 |
$16M |
|
1.6M |
9.71 |
Profound Med Corp Com New
(PROF)
|
0.3 |
$15M |
|
1.7M |
9.00 |
Ptc Therapeutics Note 3.000% 8/1 (Principal)
|
0.3 |
$15M |
|
15M |
1.04 |
Alector
(ALEC)
|
0.3 |
$15M |
|
1.1M |
14.25 |
Xilio Therapeutics
(XLO)
|
0.3 |
$15M |
|
2.1M |
7.07 |
Oak Str Health Note 3/1 (Principal)
|
0.3 |
$14M |
|
18M |
0.80 |
Springworks Therapeutics
(SWTX)
|
0.3 |
$14M |
|
250k |
56.44 |
Evolus
(EOLS)
|
0.3 |
$14M |
|
1.2M |
11.22 |
Kalvista Pharmaceuticals
(KALV)
|
0.3 |
$12M |
|
831k |
14.74 |
Cogent Biosciences
(COGT)
|
0.3 |
$12M |
|
1.6M |
7.49 |
Merus N V
(MRUS)
|
0.3 |
$12M |
|
437k |
26.44 |
Kinnate Biopharma
(KNTE)
|
0.2 |
$11M |
|
986k |
11.26 |
Apollo Endosurgery
|
0.2 |
$11M |
|
1.8M |
6.05 |
Sarissa Capital Acquisitn Cl A
|
0.2 |
$9.9M |
|
1000k |
9.90 |
Eucrates Biomedical Acqu Cor SHS
|
0.2 |
$9.8M |
|
1000k |
9.84 |
Senior Connect Acquisitn Cor Com Cl A
|
0.2 |
$9.8M |
|
1.0M |
9.82 |
Revolution Healthcar Aq Corp Class A Com
|
0.2 |
$9.8M |
|
1.0M |
9.81 |
Medtech Acquisition Corp Com Cl A
|
0.2 |
$9.8M |
|
1000k |
9.80 |
Inozyme Pharma
(INZY)
|
0.2 |
$9.6M |
|
2.3M |
4.09 |
An2 Therapeutics
(ANTX)
|
0.2 |
$8.8M |
|
584k |
15.07 |
Nyxoah S A SHS
(NYXH)
|
0.2 |
$8.7M |
|
455k |
19.14 |
Turmeric Acquisition Corp Cl A
|
0.2 |
$7.4M |
|
750k |
9.85 |
Insmed Com Par $.01
(INSM)
|
0.2 |
$7.2M |
|
305k |
23.50 |
Ignyte Acquisition Corp
|
0.2 |
$7.1M |
|
725k |
9.84 |
Terns Pharmaceuticals
(TERN)
|
0.2 |
$7.0M |
|
2.3M |
2.97 |
Quantum Si Com Cl A
(QSI)
|
0.1 |
$6.6M |
|
1.4M |
4.68 |
Graybug Vision Com Shs
|
0.1 |
$6.5M |
|
5.3M |
1.23 |
Benefitfocus Note 1.250%12/1
|
0.1 |
$6.3M |
|
6.5M |
0.97 |
Oncorus
|
0.1 |
$5.6M |
|
3.1M |
1.78 |
Vincerx Pharma Com New
(VINC)
|
0.1 |
$5.5M |
|
1.4M |
4.00 |
Orchard Therapeutics Ads
|
0.1 |
$4.9M |
|
6.9M |
0.71 |
Orion Acquisition Corp Com Cl A
|
0.1 |
$4.9M |
|
500k |
9.77 |
Werewolf Therapeutics
(HOWL)
|
0.1 |
$4.2M |
|
958k |
4.40 |
Cullinan Oncology
(CGEM)
|
0.1 |
$3.9M |
|
376k |
10.47 |
Acutus Medical
(AFIB)
|
0.1 |
$3.7M |
|
2.6M |
1.39 |
Foghorn Therapeutics
(FHTX)
|
0.1 |
$3.6M |
|
239k |
15.23 |
Rhythm Pharmaceuticals
(RYTM)
|
0.1 |
$3.4M |
|
291k |
11.52 |
Delcath Sys Com New
(DCTH)
|
0.1 |
$3.2M |
|
500k |
6.40 |
Neogenomics Note 0.250% 1/1 (Principal)
|
0.0 |
$1.7M |
|
2.5M |
0.67 |
American Well Corp Cl A
(AMWL)
|
0.0 |
$1.6M |
|
391k |
4.21 |
Annexon
(ANNX)
|
0.0 |
$1.6M |
|
584k |
2.73 |
Bioatla
(BCAB)
|
0.0 |
$1.4M |
|
289k |
5.00 |
The Oncology Institute *w Exp 11/15/202
(TOIIW)
|
0.0 |
$1.4M |
|
1.3M |
1.15 |
Caremax *w Exp 06/08/202
(CMAXW)
|
0.0 |
$1.3M |
|
672k |
1.90 |
Medavail Holdings Ord
|
0.0 |
$1.1M |
|
1.1M |
0.97 |
Cabaletta Bio
(CABA)
|
0.0 |
$942k |
|
464k |
2.03 |
Roivant Sciences *w Exp 09/30/202
|
0.0 |
$880k |
|
1.0M |
0.88 |
Butterfly Network *w Exp 02/12/202
(BFLY.WS)
|
0.0 |
$748k |
|
733k |
1.02 |
Quantum Si *w Exp 06/10/202
(QSIAW)
|
0.0 |
$383k |
|
333k |
1.15 |
Somalogic *w Exp 08/31/202
|
0.0 |
$257k |
|
120k |
2.14 |
Nuvation Bio *w Exp 07/07/202
(NUVB.WS)
|
0.0 |
$135k |
|
167k |
0.81 |
Ignyte Acquisition Corp *w Exp 01/05/202
|
0.0 |
$132k |
|
363k |
0.36 |
Sarissa Capital Acquisitn *w Exp 10/23/202
|
0.0 |
$120k |
|
333k |
0.36 |
Senior Connect Acquisitn Cor *w Exp 12/31/202
|
0.0 |
$90k |
|
500k |
0.18 |
Revolution Healthcar Aq Corp *w Exp 12/31/202
|
0.0 |
$90k |
|
200k |
0.45 |
Medtech Acquisition Corp *w Exp 12/22/202
|
0.0 |
$85k |
|
333k |
0.26 |
Turmeric Acquisition Corp *w Exp 10/08/202
|
0.0 |
$82k |
|
250k |
0.33 |
Eucrates Biomedical Acqu Cor *w Exp 10/23/202
|
0.0 |
$62k |
|
333k |
0.19 |
Surrozen *w Exp 08/01/203
(SRZNW)
|
0.0 |
$42k |
|
167k |
0.25 |
Orion Acquisition Corp *w Exp 02/19/202
|
0.0 |
$39k |
|
125k |
0.31 |
Windtree Therapeutics
|
0.0 |
$23k |
|
20k |
1.14 |
Pmv Pharmaceuticals
(PMVP)
|
0.0 |
$10k |
|
470.00 |
21.28 |
Eucrates Biomedical Acqu Cor Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Sarissa Capital Acquisitn Unit 10/23/2027
|
0.0 |
$0 |
|
1.00 |
0.00 |
Medtech Acquisition Corp Unit 12/18/2025
|
0.0 |
$0 |
|
1.00 |
0.00 |